UY25179A1 - Nuevos derivados de 2-(3h)-oxazolona - Google Patents

Nuevos derivados de 2-(3h)-oxazolona

Info

Publication number
UY25179A1
UY25179A1 UY25179A UY25179A UY25179A1 UY 25179 A1 UY25179 A1 UY 25179A1 UY 25179 A UY25179 A UY 25179A UY 25179 A UY25179 A UY 25179A UY 25179 A1 UY25179 A1 UY 25179A1
Authority
UY
Uruguay
Prior art keywords
formula
alkyl
compounds
fever
compound
Prior art date
Application number
UY25179A
Other languages
English (en)
Spanish (es)
Inventor
Maria Isabel Crespo Crespo
Juan M Jimenez Mayorga
Carles Puig Duran
Joan Feixas Gras
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of UY25179A1 publication Critical patent/UY25179A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
UY25179A 1997-09-12 1998-09-11 Nuevos derivados de 2-(3h)-oxazolona UY25179A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701928A ES2131015B1 (es) 1997-09-12 1997-09-12 Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.

Publications (1)

Publication Number Publication Date
UY25179A1 true UY25179A1 (es) 2000-12-29

Family

ID=8300586

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25179A UY25179A1 (es) 1997-09-12 1998-09-11 Nuevos derivados de 2-(3h)-oxazolona

Country Status (10)

Country Link
EP (1) EP1017685A1 (ja)
JP (1) JP2001516750A (ja)
AR (1) AR017097A1 (ja)
AU (1) AU9623698A (ja)
CO (1) CO5011110A1 (ja)
ES (1) ES2131015B1 (ja)
PE (1) PE116999A1 (ja)
UY (1) UY25179A1 (ja)
WO (1) WO1999014205A1 (ja)
ZA (1) ZA988303B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
ES2166710B1 (es) * 2000-04-25 2004-10-16 J. URIACH & CIA, S.A. Nuevos compuestos heterociclicos con actividad antiinflamatoria.
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
AU5860396A (en) * 1995-05-19 1996-11-29 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
ES2125161B1 (es) * 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique

Also Published As

Publication number Publication date
WO1999014205A1 (en) 1999-03-25
CO5011110A1 (es) 2001-02-28
ZA988303B (en) 1999-03-11
EP1017685A1 (en) 2000-07-12
PE116999A1 (es) 1999-12-13
AU9623698A (en) 1999-04-05
JP2001516750A (ja) 2001-10-02
ES2131015B1 (es) 2000-03-01
AR017097A1 (es) 2001-08-22
ES2131015A1 (es) 1999-07-01

Similar Documents

Publication Publication Date Title
HUP0001446A2 (hu) HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
DZ799A1 (fr) Composés bicycliques substitués.
FI850140A0 (fi) Kemiska foereningar.
PE20040698A1 (es) Derivados de isoindolina
UY25179A1 (es) Nuevos derivados de 2-(3h)-oxazolona
NO156286C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidderivater.
BR0207644A (pt) Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
SE8802412D0 (sv) Thiourea derivatives
UY24499A1 (es) Nuevos derivados de 2-(3h)-oxazolona
ES2175405T3 (es) Derivados de adenosina.
BR0207830A (pt) Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
NO167029C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
NO913543L (no) Fremgangsmaate for fremstilling av 3-(1h-indazol-3-yl)-4-pyridinaminer og mellomprodukter, og anvendelse som medikamenter.
NO166125C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte dihydro-1,4-tiaziner.
ES2135165T3 (es) Procedimiento para la preparacion de loracarbef monohidratado.
RU95110868A (ru) Новые конденсированные производные тиазола, способ его получения и его фармацевтическая композиция
DK316986A (da) Kemiske forbindelser, som er phosphodiesterase type iii inhibitorer
YU54196A (sh) Hemijska jedinjenja
NO803862L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater
NO171363C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksysalicylaminoderivater
ECSP993203A (es) Derivados de pirazolopiridina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121129